I’m not expecting the Class B milestone to be met. It requires $15m revenue in the 12 months to 28 Feb 2019.
That includes 4 months of Fy18 revenue before the MKM acquisition, and the first 8 months of FY 19 revenue which includes MKM revenue.
Fy18 revenue was $4.2 mil, so 4 months worth is $1.4m
Fy19 cash flow to date is $9 mil over 6 months, so 8 months worth is around 12 mil.
Thus I estimate total revenue over the period of $13.4 mil.
This is just an estimate and can be wrong because of uneven timings, differences between cash flow and revenue.
So I agree that there is some risk that the milestone will be met, giving rise to some uncertainty now.
Only one month to wait until the end of the period, the company will need to update the market about the options soon after that.
- Forums
- ASX - By Stock
- General Discussion / Social Media
I’m not expecting the Class B milestone to be met. It requires...
-
- There are more pages in this discussion • 167 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALC (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.7¢ |
Change
0.003(4.69%) |
Mkt cap ! $72.51M |
Open | High | Low | Value | Volume |
6.5¢ | 6.8¢ | 6.4¢ | $40.34K | 604.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 6.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.7¢ | 95336 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 256518 | 0.065 |
2 | 539747 | 0.064 |
1 | 200 | 0.063 |
1 | 10000 | 0.062 |
2 | 149000 | 0.061 |
Price($) | Vol. | No. |
---|---|---|
0.066 | 128118 | 1 |
0.068 | 232449 | 1 |
0.069 | 50000 | 1 |
0.070 | 160606 | 2 |
0.071 | 20177 | 1 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
ALC (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online